BioSpace News Archive

Saniona today announced that it will present at multiple upcoming virtual investor conferences this fall. Details are as follows: Aktiespararna’s Aktiedagen Stockholm 2021 Date/Time: 11 October 2021, 19.00 CEST / 1:00 p.m. EDT

Assembly Biosciences, Inc. announced participation in the below upcoming conferences focused on HBV: The Science of HBV Cure Meeting 2021 ONLINE Presenter : William Delaney, PhD, Chief Scientific Officer Date/Time : Tuesday, October 12 at 7:30 a.m. ET

Fortress Biotech, Inc. (NASDAQ: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on acquiring, developing and commercializing or monetizing promising biopharmaceutical products and product candidates cost-effectively, and a company it founded, Caelum Biosciences, Inc. (“Caelum”), a biotechnology company developing treatments for rare and life-threatening diseases with two ongoing Phase 3 clinical trials.

AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company dedicated to the development of novel therapeutics for the treatment of immunological diseases with high unmet medical needs, today announced that President and Chief Executive Officer Judy Chou, Ph.D., will present at the upcoming B&T Cell-Mediated Autoimmune Disease Drug Development Virtual Summit.

Sunshine Biopharma Inc. today announced that it has filed a patent application for a potential new treatment for neurodegenerative disorders.

Viracta Therapeutics, Inc. today announced the initiation of a multinational Phase 1b /2 trial in patients with EBV + solid tumors.

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) announced today that the Company will release its third quarter 2021 financial results on Wednesday, November 3, 2021, prior to market open.

Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF 2” or “the Fund”), making it the world’s largest biotech impact investment fund.

Altamira Therapeutics Ltd. today announced that management will participate in A.G.P.'s Virtual Biotech and Specialty Pharma Conference on October 13, 2021.

Cyclo Therapeutics, Inc. today announced it will participate in the 2021 Virtual Cyclodextrin Conference hosted by CycloLab, “Cyclodextrins as active ingredients in the 21st century,” taking place on October 11, 2021.